Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nazzaro, 2013, Effect of clustering of metabolic syndrome factors on capillary and cerebrovascular impairment, Eur J Intern Med, 24, 183, 10.1016/j.ejim.2012.08.017
Thang, 2011, Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels, Nephrol Dial Transplant, 26, 3529, 10.1093/ndt/gfr089
Tibirica, 2015, Reduced systemic microvascular density and reactivity in individuals with early onset coronary artery disease, Microvasc Res, 97, 105, 10.1016/j.mvr.2014.10.004
Triantafyllou, 2015, Capillary rarefaction as an index for the microvascular assessment of hypertensive patients, Curr Hypertens Rep, 17, 543, 10.1007/s11906-015-0543-3
Serne, 2001, Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction, Hypertension, 38, 238, 10.1161/01.HYP.38.2.238
Triantafyllou, 2014, Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients, J Am Soc Hypertens, 8, 542, 10.1016/j.jash.2014.04.008
Pauletto, 2006, Inflammation and hypertension: the search for a link, Nephrol Dial Transplant, 21, 850, 10.1093/ndt/gfl019
Marek-Trzonkowska, 2015, Arterial hypertension is characterized by imbalance of pro-angiogenic versus anti-angiogenic factors, PLoS One, 10, e0126190, 10.1371/journal.pone.0126190
Mourad, 2011, Mechanisms of antiangiogenic-induced arterial hypertension, Curr Hypertens Rep, 13, 289, 10.1007/s11906-011-0206-y
Reiner, 2011, ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158
Martell-Claros, 2012, Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study, Eur J Prev Cardiol, 19, 534, 10.1177/1741826711406202
Czernichow, 2010, Macrovascular and microvascular dysfunction in the metabolic syndrome, Hypertens Res, 33, 293, 10.1038/hr.2009.228
Kraemer-Aguiar, 2008, Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome, Metabolism, 57, 1740, 10.1016/j.metabol.2008.07.034
2001, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883
Thijs, 2013, Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans, Hypertension, 61, 1060, 10.1161/HYPERTENSIONAHA.111.00841
Lazich, 2012, Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study, Diabetes Obes Metab, 14, 181, 10.1111/j.1463-1326.2011.01510.x
Karamaounas, 2011
Debbabi, 2006, Increased skin capillary density in treated essential hypertensive patients, Am J Hypertens, 19, 477, 10.1016/j.amjhyper.2005.10.021
Gomaraschi, 2014, eNOS activation by HDL is impaired in genetic CETP deficiency, PLoS One, 9, e95925, 10.1371/journal.pone.0095925
Hamilton, 1993, Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9, J Biol Chem, 268, 3632, 10.1016/S0021-9258(18)53740-6
Xiong, 2014, High-density lipoprotein induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through sphingosine kinase-2, Mol Cell Biochem, 389, 197, 10.1007/s11010-013-1941-y
Lopes, 2013, In elderly women moderate hypercholesterolemia is associated to endothelial and microcirculatory impairments, Microvasc Res, 85, 99, 10.1016/j.mvr.2012.10.009
Haak, 2001, Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia, Atherosclerosis, 155, 395, 10.1016/S0021-9150(00)00567-0
Haak, 1998, Fenofibrate improves microcirculation in patients with hyperlipidemia, Eur J Med Res, 3, 50
Serne, 2002, Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia, Diabetes, 51, 1515, 10.2337/diabetes.51.5.1515
Kraemer de Aguiar, 2007, Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome, Diabet Med, 24, 272, 10.1111/j.1464-5491.2007.02082.x
Wiernsperger, 2007, Microcirculation and the metabolic syndrome, Microcirculation, 14, 403, 10.1080/10739680701285617
Jonk, 2007, Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension, Physiology (Bethesda), 22, 252, 10.1152/physiol.00012.2007
Serne, 2007, Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome, Hypertension, 50, 204, 10.1161/HYPERTENSIONAHA.107.089680
Cheng, 2015, Association of adipokines with insulin resistance, Microvascular dysfunction, and endothelial dysfunction in healthy young adults, Mediators Inflamm, 2015, 594039, 10.1155/2015/594039
Mourad, 2008, Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation, Ann Oncol, 19, 927, 10.1093/annonc/mdm550
Steeghs, 2008, Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor, Clin Cancer Res, 14, 3470, 10.1158/1078-0432.CCR-07-5050
Longo, 2002, Anti-angiogenic therapy: rationale, challenges and clinical studies, Angiogenesis, 5, 237, 10.1023/A:1024532022166
Groen, 2014, Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes, J Appl Physiol (1985), 116, 998, 10.1152/japplphysiol.00919.2013
Antonios, 1999, Structural skin capillary rarefaction in essential hypertension, Hypertension, 33, 998, 10.1161/01.HYP.33.4.998
Prasad, 1995, Capillary rarefaction in the forearm skin in essential hypertension, J Hypertens, 13, 265, 10.1097/00004872-199502000-00015